Neuromod’s Tinnitus Treatment Device Expands Availability in Spain
Lenire’s Spanish launch began in Barcelona. This latest expansion brings the number of clinics in Spain providing Lenire to four.
Lenire’s Spanish launch began in Barcelona. This latest expansion brings the number of clinics in Spain providing Lenire to four.
Neuromod Devices Ltd, the medical device company which specializes in neuromodulation technologies, has announced the appointment of Teri Minard as Director, Government Sales of its recently established US entity, Neuromod USA Inc.
The clinical trial was conducted between 2016 and 2019 and was designed to track changes in tinnitus symptom severity. The trial investigated the bimodal neuromodulation approach, using Neuromod’s non-invasive stimulation device that delivers sound to the ears and electrical stimulation to the tongue.
Neuromod Devices Limited (“Neuromod”), an Irish medical technology company specializing in non-invasive neuromodulation technologies, is pleased to announce that Christopher M. Smith is a Strategic Advisor to the Board as of June 1, 2018 and will join the company’s Board of Directors from January 3, 2019.
Read MoreThis conference is intended for otologists, audiologists, psychologists, hearing aid specialists, and nurses who provide clinical management services for patients with tinnitus.
Read MoreLim’s work has a strong focus on the improvement of invasive and non-invasive neurostimulation approaches for treating unmet medical needs in hearing and other therapeutic areas.
Read MoreNeuromod Devices announced that it has secured the CE Mark—certified regulatory approval in Europe—for its mutebutton multisensory tinnitus treatment device.
Read More